Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)
Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%
Phibro Animal Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Phibro Animal Health's enterprise value was $1.97B on Nov 11, 2026, against $2.25B a year earlier. Over the last 5 years it ranged from $626.15M to $2.81B, with a median of $1.04B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.97B | -4.4% |
| 2025 | Dec 31, 2025 | $2.07B | +95.4% |
| 2024 | Dec 31, 2024 | $1.06B | +49.5% |
| 2023 | Dec 29, 2023 | $706.75M | -6.1% |
| 2022 | Dec 30, 2022 | $753.04M | -27.3% |
| 2021 | Dec 31, 2021 | $1.04B | +11.6% |
| 2020 | Dec 31, 2020 | $928.34M | +2.8% |
| 2019 | Dec 31, 2019 | $903.05M | +84.1% |
| 2018 | Dec 31, 2018 | $490.55M | -5.8% |
| 2017 | Dec 29, 2017 | $520.78M | -21.7% |
| 2016 | Jul 29, 2016 | $665.01M | -42.5% |
| 2015 | Dec 31, 2015 | $1.16B | -10.0% |
| 2014 | Dec 31, 2014 | $1.28B | – |
See a number that looks wrong?